Gilead Sciences (NASDAQ: GILD) | Will Sales Fall After Warning?

Gilead Sciences Inc. (NASDAQ: GILD) When it comes to the world of medicine, Gilead Sciences is a major player. As a matter of fact, the company currently leads the world in both HIV and hepatitis C treatments. However, they did take a decent hit in the stock market Monday after sending a warning to doctors … Read more

Gilead Sciences (NASDAQ: GILD) Stock | Is It Time To Buy?

Gilead Sciences, Inc – (NASDAQ: GILD) Throughout most of the past month, Gilead Sciences stocks have been on the downtrend. However, as investors, our ultimate goal is to find the bottom so we can buy in cheap and gain from growth. So, today I thought I would talk about why I think that if you’re … Read more

Biotech News- 2/9/15 to 2/13/15

Achillion Pharmaceuticals (ACHN) Shares of Achillion gained 7% on 2/9/15 last week when it had announced that it had achieved a 100% SVR12 in a phase 2 trial treating patients with the genotype 1 version of the Hepatitis C virus — HCV. The trial tested for the primary objective of patients being able to achieve a … Read more